All stock lists
Akari Therapeutics Plc (NASDAQ:AKTX)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
8.10-0.13 (-1.52%)
Insider Score
––Not scored
AKTX Insider Score
Insiders here have filed 18 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
AKTX Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 2.52 M | 2.17 M | 2.14 M | 1.98 M | 2.45 M | 2.71 M |
| R&D Expense | 2.08 M | 1.46 M | 1.09 M | 249.00 K | 667.00 K | 813.00 K |
| Operating Expenses | 4.60 M | 15.76 M | 3.23 M | 7.40 M | 3.12 M | 3.52 M |
| Operating Income | -4.60 M | -15.76 M | -3.23 M | -7.40 M | -3.12 M | -3.52 M |
| Pretax Income | -4.81 M | -15.31 M | -5.21 M | -7.49 M | -1.90 M | -3.71 M |
| Tax Provision | 0.00 | -859.00 K | 85.00 K | -1.09 M | 0.00 | 0.00 |
| Net Income | -4.81 M | -14.46 M | -5.30 M | -6.40 M | -1.90 M | -3.71 M |
| EPS (Basic) | -272.00 | -688.00 | -248.00 | -392.00 | -120.00 | -272.00 |
| EPS (Diluted) | -272.00 | -688.00 | -248.00 | -392.00 | -120.00 | -272.00 |
| Shares Outstanding | 1.79 M | 21.04 K | 21.04 K | 16.33 K | 15.73 K | 13.65 K |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.